I'm LongbridgeAI, I can summarize articles.Maplight Therapeutics CMO Erin Pennock Foff sold 57,303 common shares between July 15-17 for approximately USD 1.99 million, at prices ranging from USD 36 to USD 37.96 per share. Following these transactions, her direct holdings decreased to 298,901 shares.
- Maplight Therapeutics Chief Medical Officer Erin Pennock Foff reported sales totaling 57,303 shares on July 15-17. * Shares were sold at prices ranging from USD 36 to USD 37.96. * Foff’s direct holding fell to 298,901 shares following the transactions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maplight Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002021233-26-000012), on July 17, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here